Document is current
Any future updates will be listed below
-
Authors
Wang, Karen S.
Smeyers, Julie
Eggan, Kevin
Budnik, Bogdan
Mordes, Daniel A.
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (K08NS104270)
- License Information
-
More Information
Article History
Received: 3 October 2024
Accepted: 2 March 2025
First Online: 26 March 2025
Declarations
:
: The usage of human induced pluripotent stem cells (iPSCs) was approved by the Human Gamete, Embryo and Stem Cell Research (GESCR) Committee at UCSF.
: Not applicable.
: K.E. is a co-founder of Quralis and Enclear Therapies, and currently employed at BioMarin Pharmaceutical. D.A.M. receives sponsored research support from Genentech/Roche that is unrelated to this study. The remaining authors declare no competing interests.
